The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Bausch Health Companies Inc shares valued at $21,170,510 were purchased by Paulson John on Jun 13 ’25. At $5.94 per share, Paulson John acquired 3,564,059 shares. The insider’s holdings grew to 32,791,702 shares worth approximately $209.21 million following the completion of this transaction.
Also, Paulson John purchased 1,005,376 shares, netting a total of over 5,499,407 in proceeds. Following the buying of shares at $5.47 each, the insider now holds 29,227,643 shares.
Before that, Paulson John had added 1,029,098 shares to its account. In a trade valued at $5,392,474, the Director bought Bausch Health Companies Inc shares for $5.24 each. Upon closing the transaction, the insider’s holdings increased to 1,029,098 shares, worth approximately $180.06 million.
As published in a research note from Piper Sandler on August 02, 2024, Bausch Health Companies Inc [BHC] has been rated down from a Neutral to an Underweight and the price target has been revised to $3 from $9. Analysts at Raymond James started covering the stock with ‘”a Mkt perform”‘ outlook in a report released in early July. As of September 20, 2023, Jefferies has increased its “Hold” rating to a “Buy” for BHC. Earlier on June 16, 2023, TD Cowen downgraded its rating. Their new recommendation was “a Market perform” for BHC stock which previously was a “an Outperform”.
Analyzing BHC Stock Performance
On last trading session,, Bausch Health Companies Inc [NYSE: BHC] rose 2.90% to $6.38. The stock’s lowest price that day was $6.2, but it reached a high of $6.425 in the same session. During the last five days, there has been a surge of approximately 11.34%. Over the course of the year, Bausch Health Companies Inc shares have dropped approximately -6.18%. Shares of the company reached a 52-week high of $8.27 on 01/02/25 and a 52-week low of $4.25 on 04/11/25.
Support And Resistance Levels for Bausch Health Companies Inc (BHC)
According to the 24-hour chart, there is a support level at 6.24, which, if violated, would cause prices to drop to 6.11. In the upper region, resistance lies at 6.47. The next price resistance is at 6.57. RSI (Relative Strength Index) is 74.70 on the 14-day chart, showing overbought technical sentiment.
Is Bausch Health Companies Inc subject to short interest?
Stocks of Bausch Health Companies Inc saw a sharp steep in short interest on 2025-05-30 dropping by -1.26 million shares to 8.61 million. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 9.86 million shares. A decline of -14.61% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 5.26 of the overall float, the days-to-cover ratio (short ratio) decline to 5.26.
Which companies own the most shares of Bausch Health Companies Inc (BHC)?
In terms of Bausch Health Companies Inc share price expectations, FactSet research, analysts set an average price target of 9 in the next 12 months, up nearly 45.16% from the previous closing price of $6.2. Analysts anticipate Bausch Health Companies Inc stock to reach 16 by 2025, with the lowest price target being 7. In spite of this, 4 analysts ranked Bausch Health Companies Inc stock as Hold at the end of 2025.
